Aker BioMarine ASA – Invitation to presentation of the fourth quarter 2024 results

10 Feb 2025 17:40 CET

Aker BioMarine will release the fourth quarter 2024 results on Wednesday 12
February 2025 at 07:00 CET.

At 09:00 CET on the same day, the management will host a webcast to present the
results. Following a presentation, there will be a Q&A session where written
questions can be submitted to ir@akerbiomarine.com.

The webcasted presentation will be in English. To join, please use the link that
will be available at www.akerbiomarine.com/investor.

A replay of the presentation and Q&A session will be made available soon after
the presentation at the same web page.

For further information, please contact
Christopher Robin Vinter, VP Strategic Finance & IR
Mobile: +47 911 60 820
Email: christopher.vinter@akerbiomarine.com


About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and
PL+, as well as the consumer brand, Kori Krill. The innovative approach also
extends into the spin-offs AION (reduce and recycle plastic waste across
industries) and Understory (a protein brand). Aker BioMarine is listed on the
Oslo Stock Exchange (AKBM). More information is available at
www.akerbiomarine.com.

More information:
Access the news on Oslo Bors NewsWeb site